10487-86-2 Usage
Description
(1R,2R)-2-Methylcyclopropane-1-carboxylic acid is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its unique cyclopropane ring structure and a carboxylic acid functional group, which contribute to its reactivity and potential applications in the chemical and pharmaceutical industries.
Uses
Used in Pharmaceutical Synthesis:
(1R,2R)-2-Methylcyclopropane-1-carboxylic acid is used as a key intermediate for the synthesis of (1R,2R)-trans-1-(Chloromethyl)-2-methylcyclopropane (C369820), a compound with potential pharmaceutical applications.
Used in HIV Treatment:
In the field of HIV treatment, (1R,2R)-2-Methylcyclopropane-1-carboxylic acid is utilized as a starting material for the preparation of Luzopeptin A-C and Quinoxapeptin A-C. These compounds have been identified as potent inhibitors of HIV-1 reverse transcriptase, playing a significant role in the development of antiretroviral therapies.
Used in Chemical Synthesis:
(1R,2R)-2-Methylcyclopropane-1-carboxylic acid can also be employed in various chemical synthesis processes due to its reactive cyclopropane ring and carboxylic acid group. This makes it a versatile building block for creating a range of chemical compounds with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 10487-86-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,8 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 10487-86:
(7*1)+(6*0)+(5*4)+(4*8)+(3*7)+(2*8)+(1*6)=102
102 % 10 = 2
So 10487-86-2 is a valid CAS Registry Number.
10487-86-2Relevant articles and documents
Gassman et al.
, p. 6055,6056 (1976)
PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
-
, (2014/06/11)
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflamation, asthma, COPD and cancer.
3-INDAZOLYL-4-PYRIDYLISOTHIAZOLES
-
Page/Page column 7, (2009/10/18)
The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.
A short and efficient synthesis of (R,R)-2-methylcyclopropanecarboxylic acid
Delhaye, Laurent,Merschaert, Alain,Delbeke, Pieter,Brione, Willy
supporting information, p. 689 - 692 (2012/12/29)
We report herein a short and efficient synthesis of (R,R)-2- methylcyclopropanecarboxylic acid via a Horner-Wadsworth-Emmons reaction involving commercially available (S)-propylene oxide and triethylphosphonoacetate (TEPA). The TEPA/base/propylene oxide stoichiometry was found critical to achieve high yields. We therefore studied the TEPA anion formation and stability using in situ IR spectroscopy. The reaction yield is strongly influenced by the counterion and solvent, whereas high diastereoselectivities are always obtained. Under the best experimental conditions (HexLi/MeTHF/150 °C), crude (R,R)-2-methylcyclopropanecarboxylic acid is obtained in 85-90% yield with >98% trans selectivity.